Healthcare - Medical - Devices - NYSE - US
$ 237.84
1.85 %
$ 9.13 B
Market Cap
273.38
P/E
CASH FLOW STATEMENT
97.3 M
OPERATING CASH FLOW
-16.1 M
INVESTING CASH FLOW
16.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Penumbra, Inc.
| Net Income | 91 M |
| Depreciation & Amortization | 27.3 M |
| Capital Expenditures | -15.2 M |
| Stock-Based Compensation | 50.5 M |
| Change in Working Capital | -79.1 M |
| Others | 14.5 M |
| Free Cash Flow | 82.1 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | 91.0 | (2.0) | 2.6 | (19.3) | 47.0 | 2.9 | 4.7 | 14.8 | 2.4 | 2.2 | 4.1 |
| Depreciation & Amortization | 27.3 | 24.3 | 16.4 | 12.9 | 8.1 | 6.2 | 3.8 | 2.3 | 1.8 | 0.8 | 0.7 |
| Deferred Income Tax | (19.1) | 1.5 | (14.1) | (18.8) | 1.8 | (6.5) | (4.3) | (12.4) | (3.0) | (0.6) | (0.3) |
| Stock Based Compensation | 50.5 | 37.4 | 65.8 | 25.5 | 21.5 | 18.4 | 17.8 | 14.6 | 7.3 | 1.4 | 0.9 |
| Other Operating Activities | 26.8 | 5.0 | 9.2 | 17.6 | 5.1 | 38.0 | 4.2 | 4.0 | 1.6 | 1.9 | (3.7) |
| Change in Working Capital | (79.1) | (121.8) | (70.4) | (51.2) | (56.8) | (30.3) | (13.5) | (36.2) | (32.3) | (12.1) | (5.0) |
| Cash From Operations | 97.3 | (55.7) | 9.5 | (33.2) | 26.7 | 28.8 | 12.7 | (12.8) | (22.3) | (6.4) | (3.4) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (15.2) | (19.3) | (21.2) | (24.8) | (22.1) | (9.6) | (15.0) | (13.6) | (5.5) | (3.9) | (0.8) |
| Other Items | (0.9) | 74.1 | (0.6) | (79.4) | 9.4 | 9.2 | (62.6) | 14.3 | (80.3) | (33.1) | (0.5) |
| Cash From Investing Activities | (16.1) | 54.8 | (21.7) | (104.1) | (12.7) | (0.4) | (77.7) | 0.7 | (85.8) | (37.0) | (1.3) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | (2.1) | (8.0) | (15.8) | 0 | (18.5) | (17.7) | 0 | (2.6) | 0 | (9.4) | 0 |
| Total Debt Repaid | (2.0) | (1.8) | (1.5) | (3.4) | (2.6) | (0.4) | (1.1) | 0 | 0 | (6.0) | 2.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 18.2 | 13.4 | 2.3 | 3.6 | (6.4) | (9.4) | (0.8) | 7.1 | (0.3) | 49.9 | 0.2 |
| Cash From Financing Activities | 16.2 | 11.6 | 0.8 | 134.9 | (9.0) | (9.8) | 104.4 | 7.1 | 124.4 | 42.9 | 2.2 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 97.6 | 10.5 | (10.3) | (3.1) | 4.9 | 17.2 | 37.4 | (6.3) | 16.3 | (0.8) | (3.3) |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | 82.1 | (75.0) | (11.7) | (58.0) | 4.5 | 19.2 | (2.3) | (26.4) | (27.8) | (10.3) | (4.2) |